Trials
Search / Trial NCT00000504

Cardiac Arrhythmia Pilot Study (CAPS)

Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Oct 27, 1999

Trial Information

Current as of January 15, 2025

Completed

Keywords

ClinConnect Summary

BACKGROUND:

Epidemiologic studies had indicated that complex ventricular premature beats made an independent contribution to risk of sudden death in survivors of a myocardial infarction (MI), and did not appear to be merely a reflection of their association with relatively severe myocardial damage. The potential for reduction in mortality by identification and administration of drugs capable of safely suppressing ventricular arrhythmias was tremendous. In 1982, there was incomplete knowledge regarding which types of ventricular arrhythmias responded to various kinds of drugs. A pilot study...

Gender

ALL

Eligibility criteria

  • Men and women. Patients had acute myocardial infarction and ventricular arrhythmias.

Trial Officials

Toshio Akiyama

University of Rochester

Allan Barker

Salt Lake Clinic Research Foundation

J. Bigger

Columbia University

Robert Capone

Rhode Island Hospital

Lawrence Griffith

Johns Hopkins University

Craig Pratt

Baylor College of Medicine

David Richardson

Medical College of Virginia

William Rogers

University of Alabama at Birmingham

Michael Sather

V.A. Medical Center

Israel Stein

Clinical Data, Inc

Pierre Theroux

Montreal Heart Institute

Raymond Woosley

Vanderbilt University Medical Center

About National Heart, Lung, And Blood Institute (Nhlbi)

The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials